GlassScriptPhysician profile
Don V Jackson
NPI 1154361699
$3,837.12
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,858 · 2020: $664 · 2021: $189 · 2022: $126.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $524.94 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $300.85 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $299.32 | 2019-2020 | |
| Pfizer INC. | $296.85 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $292.03 | 2019-2020 | |
| Amgen INC. | $214.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $161.66 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.95 | 2019-2020 | |
| Incyte Corporation | $134.32 | 2019-2020 | |
| Daiichi Sankyo INC. | $130.67 | 2019-2020 | |
| Seagen INC. | $123.02 | 2019-2022 | |
| Genentech USA, INC. | $114.62 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $108.63 | 2019-2020 | |
| Genzyme Corporation | $106.45 | 2019-2020 | |
| Lilly USA, LLC | $104.98 | 2019-2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $96.67 | 2019 | |
| Gilead Sciences, INC. | $89.31 | 2019 | |
| Exelixis INC. | $82.35 | 2019-2020 | |
| Taiho Oncology, INC. | $62.45 | 2019 | |
| Celgene Corporation | $44.33 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.59 | 2019-2020 | |
| Kyowa Kirin, INC. | $31.13 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $30.59 | 2019 | |
| Tersera Therapeutics LLC | $28.54 | 2021 | |
| Astellas Pharma US INC | $28.02 | 2019 | |
| Alexion Pharmaceuticals, INC. | $28.00 | 2019-2020 | |
| Tactile Systems Technology INC | $27.72 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $24.27 | 2019 | |
| Kite Pharma, INC. | $23.61 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $23.38 | 2019 | |
| Karyopharm Therapeutics INC. | $18.01 | 2020 | |
| Eisai INC. | $17.91 | 2019 | |
| Advanced Accelerator Applications | $16.45 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $16.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.24 | 2019 | |
| Array Biopharma INC | $13.61 | 2020 | |
| Csl Behring | $13.54 | 2019 | |
| Emd Serono, INC. | $10.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.